Everist to introduce CardioDefender diagnostic system
Everist Genomics, a developer of gene-based molecular assays, is planning to introduce its CardioDefender diagnostic system.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Nov 11
Everist Genomics, a developer of gene-based molecular assays, is planning to introduce its CardioDefender diagnostic system.
10 Nov 11
GeneNews Diagnostics, a subsidary of GeneNews, has introduced ColonSentry in Malaysia.
09 Nov 11
Medtronic has started enrolling US patients for Enlite Sensor investigational device exemption (IDE) study for Continuous Glucose Monitoring…
09 Nov 11
Cerapedics has received the US patent 8,048,443 which protects the manufacture method of i-Factor Biologic Bone Graft in…
09 Nov 11
Sunshine Heart has reported positive results from the US Food and Drug Administration (FDA) approved feasibility clinical trial…
09 Nov 11
Kensey Nash has received a two-year Phase II Small Business Innovation Research (SBIR) grant from National Institutes of…
09 Nov 11
Medtronic has received CE mark for its direct aortic system, CoreValve, a transcatheter aortic valve implantation (TAVI) system…
09 Nov 11
DV Care, a subsidary of DaVita, has completed the acquisition of German based company- ExtraCorp.
09 Nov 11
Westhouse Medical Services has acquired new breast cancer screening device, BreastCheck, and patents.
09 Nov 11
Dako has entered into a new collaboration agreement with Bristol-Myers Squibb to develop pharmacodiagnostic tests.